USANA Health Sciences, Inc. (USNA) Stock Grade

About USANA Health Sciences, Inc.'s fundamentals

USANA Health Sciences generated 8.3% year-over-year revenue growth, though profitability remains constrained with a net margin of just 1.2%, indicating that only a penny of profit is generated per dollar of sales. The company's return on equity stands at 2.0%, reflecting modest returns on shareholder capital, while its P/E ratio of 33.6 is elevated relative to its profitability metrics. With a market capitalization of $273.6 million and no dividend yield, the company reinvests earnings rather than returning cash to shareholders. These metrics suggest a relatively small-cap business with low profit conversion despite solid revenue expansion.